134 related articles for article (PubMed ID: 8123588)
1. Characterization of somatostatin receptors on human neuroblastoma tumors.
O'Dorisio MS; Chen F; O'Dorisio TM; Wray D; Qualman SJ
Cell Growth Differ; 1994 Jan; 5(1):1-8. PubMed ID: 8123588
[TBL] [Abstract][Full Text] [Related]
2. Identification, characterization, and biological activity of somatostatin receptors in human neuroblastoma cell lines.
Maggi M; Baldi E; Finetti G; Franceschelli F; Brocchi A; Lanzillotti R; Serio M; Camboni MG; Thiele CJ
Cancer Res; 1994 Jan; 54(1):124-33. PubMed ID: 8261433
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of somatostatin receptors by epidermal growth factor and gastrin in pancreatic cancer cells.
Vidal C; Rauly I; Zeggari M; Delesque N; Esteve JP; Saint-Laurent N; Vaysse N; Susini C
Mol Pharmacol; 1994 Jul; 46(1):97-104. PubMed ID: 8058063
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro.
Weckbecker G; Liu R; Tolcsvai L; Bruns C
Cancer Res; 1992 Sep; 52(18):4973-8. PubMed ID: 1325289
[TBL] [Abstract][Full Text] [Related]
5. Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors.
Virgolini I; Yang Q; Li S; Angelberger P; Neuhold N; Niederle B; Scheithauer W; Valent P
Cancer Res; 1994 Feb; 54(3):690-700. PubMed ID: 7905785
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a neuronal cell line expressing native human melanin-concentrating hormone receptor 1 (MCHR1).
Fry D; Dayton B; Brodjian S; Ogiela C; Sidorowicz H; Frost LJ; McNally T; Reilly RM; Collins CA
Int J Biochem Cell Biol; 2006; 38(8):1290-9. PubMed ID: 16524757
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification.
Reubi JC; Waser B; Laissue JA; Gebbers JO
Cancer Res; 1996 Apr; 56(8):1922-31. PubMed ID: 8620515
[TBL] [Abstract][Full Text] [Related]
8. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
Siehler S; Nunn C; Zupanc GK; Hoyer D
Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
[TBL] [Abstract][Full Text] [Related]
9. Multiply radioiodinated somatostatin analogs induce receptor-specific cytotoxicity.
Meyers MO; Anthony CT; Coy DH; Murphy WA; Drouant GJ; Fuselier J; Espenan GD; Maloney TJ; Woltering EA
J Surg Res; 1998 May; 76(2):154-8. PubMed ID: 9698516
[TBL] [Abstract][Full Text] [Related]
10. [Somatostatin receptor genes expression and effects of octreotide on orbital fibroblasts from Graves' ophthalmopathy].
Pasquali D; Notaro A; Esposito D; Vassallo P; Bonavolontà G; Bellastella A; Sinisi AA
Minerva Endocrinol; 2001 Sep; 26(3):175-9. PubMed ID: 11753241
[TBL] [Abstract][Full Text] [Related]
11. The somatostatin analogue octreotide inhibits neuroblastoma growth in vivo.
Borgström P; Hassan M; Wassberg E; Refai E; Jonsson C; Larsson SA; Jacobsson H; Kogner P
Pediatr Res; 1999 Sep; 46(3):328-32. PubMed ID: 10473050
[TBL] [Abstract][Full Text] [Related]
12. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
Weckbecker G; Raulf F; Bodmer D; Bruns C
Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptor gene expression in neuroblastoma.
Albers AR; O'Dorisio MS; Balster DA; Caprara M; Gosh P; Chen F; Hoeger C; Rivier J; Wenger GD; O'Dorisio TM; Qualman SJ
Regul Pept; 2000 Mar; 88(1-3):61-73. PubMed ID: 10706954
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma.
O'Dorisio MS; Fleshman DJ; Qualman SJ; O'Dorisio TM
Regul Pept; 1992 Feb; 37(3):213-26. PubMed ID: 1313595
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo detection of functional somatostatin receptors in canine insulinomas.
Robben JH; Visser-Wisselaar HA; Rutteman GR; van Rijk PP; van Dongen AJ; Voorhout G; van den Ingh TS; Hofland LJ; Lamberts SW
J Nucl Med; 1997 Jul; 38(7):1036-42. PubMed ID: 9225787
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin inhibits interleukin 6 release from rat cortical type I astrocytes via the inhibition of adenylyl cyclase.
Grimaldi M; Florio T; Schettini G
Biochem Biophys Res Commun; 1997 Jun; 235(1):242-8. PubMed ID: 9196070
[TBL] [Abstract][Full Text] [Related]
17. Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes.
Ferone D; Pivonello R; Van Hagen PM; Dalm VA; Lichtenauer-Kaligis EG; Waaijers M; Van Koetsveld PM; Mooy DM; Colao A; Minuto F; Lamberts SW; Hofland LJ
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E1056-66. PubMed ID: 12376335
[TBL] [Abstract][Full Text] [Related]
18. Binding and functional properties of the novel somatostatin analogue KE 108 at native mouse somatostatin receptors.
Cervia D; Langenegger D; Schuepbach E; Cammalleri M; Schoeffter P; Schmid HA; Bagnoli P; Hoyer D
Neuropharmacology; 2005 May; 48(6):881-93. PubMed ID: 15829258
[TBL] [Abstract][Full Text] [Related]
19. Characterization and regulation of the human ML1A melatonin receptor stably expressed in Chinese hamster ovary cells.
Witt-Enderby PA; Dubocovich ML
Mol Pharmacol; 1996 Jul; 50(1):166-74. PubMed ID: 8700109
[TBL] [Abstract][Full Text] [Related]
20. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
